Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of Vermont

About this trial

The goal of this clinical trial is to learn if a treatment for adults with PTSD called prolonged exposure + incentives (PE+) works to treat pregnant patients. The main question it aims to answer is:

Does PE+ decrease PTSD symptoms?

All participants will receive PE+ to see if their PTSD symptoms at the end of the trial are less than at the beginning.

Participants will:

* Receive individual PE+ therapy for 1 hour weekly for 12 weeks. * Receive financial incentives for attending each PE+ session. * Attend assessment visits every 4 weeks for the 12 weeks of the trial. * Allow research staff to collect some information about their labor and delivery from their medical records after their babies are born.

Eligibility criteria

Qualifiers

Female

>18 years old

Gestational age ≤ 25 weeks

Meet current DSM-5 posttraumatic stress disorder criteria based on the Clinician Administered PTSD Scale for DSM-5

Disqualifiers

Male

Under 18 years old

Gestational age > 25 weeks

No current diagnosis of PTSD

Trial design

Treatments tested in this trial

  • Prolonged exposure therapy + incentives for therapy session attendance

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators